Irritable Bowel Syndrome With Constipation

Gastroenterology

Prevalence

11200.0 / 100K

Incidence

400.0 / 100K/yr

7 drugs in development·4 companies·3 clinical trials

Drug Pipeline by Phase

Phase 2(1)
DrugCompany
tenapanorARDELYX, INC. (ARDX)

Compare drugs

IBSRELA vs LINZESSIBSRELA vs trulanceIBSRELA vs tenapanor (CIC label extension / ACCEL (ten-03-301))

Frequently asked questions

How many drugs are in development for Irritable Bowel Syndrome With Constipation?

BioSniper tracks 7 drugs in development for Irritable Bowel Syndrome With Constipation across 4 companies.

How many clinical trials target Irritable Bowel Syndrome With Constipation?

There are 3 clinical trials targeting Irritable Bowel Syndrome With Constipation tracked by BioSniper.

What is the prevalence of Irritable Bowel Syndrome With Constipation?

The estimated prevalence of Irritable Bowel Syndrome With Constipation is approximately 11200.0 per 100,000 population.

Deep-dive into Irritable Bowel Syndrome With Constipation

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Irritable Bowel Syndrome With Constipation — Drugs in Development & Clinical Trials | BioSniper